Small-cap and mid-cap stocks experienced their strongest monthly performance since May 2014, with the BSE Smallcap index rising nearly 20% and the BSE Midcap index gaining almost 14% in April, significantly outpacing the Sensex's 7% rise. According to reports from Mint, this rebound was driven by recovery from oversold levels, steady domestic liquidity, selective March-quarter earnings beats, and easing geopolitical concerns following a fragile US–Iran truce. However, the recovery has been uneven, with mid-caps showing broader participation and stronger earnings support compared to small-caps, where gains have been concentrated in narrower sectors.
Despite the strong performance, valuations have climbed sharply across both segments. As reported by Mint, approximately 53% of mid-cap and 57% of small-cap stocks now trade above their five-year average price-to-earnings multiples. Of these elevated valuations, roughly 40% of mid-caps and 44% of small-caps command premiums of 50% or more. A Mint analysis of 1,411 mid- and small-cap companies shows that SMIDs remain below their 52-week highs, suggesting the rally was more a recovery from earlier lows than the beginning of a new growth phase. According to N. ArunaGiri, chief executive of TrustLine Holdings, the broad-based recovery has already played out, with markets now focusing on stock-specific stories.
Recent earnings trends reveal significant divergence between mid-cap and small-cap companies, with mid-caps demonstrating stronger fundamentals. As reported by Jahol Prajapati, research analyst at SAMCO Securities, nearly 45% of Nifty Midcap 150 companies have reported revenue growth of over 15%, while only 9% saw a decline. In contrast, small-caps were notably weaker, with about 20% reporting a fall in revenues—more than double the mid-cap reading. This divergence is becoming visible at the sector level, with mid-caps seeing broader participation across financials, industrials, utilities, renewables, consumer and commodity-linked companies, while small-caps have concentrated gains in steel, specialty chemicals and contract-led pharmaceutical companies.
Analysts expect returns to become increasingly stock-specific as the rally matures. According to Surjitt Arora, executive director and head of portfolio management services at Ambit Global Private Client, the aggressive run-up in small caps appears due for a near-term breather, with momentum potentially weakening in the June quarter of FY27 as companies face mounting macroeconomic pressures. Arunagiri noted that if oil prices spike or the rupee crashes further, volatility will return to SMIDs, as the market has been overlooking these risks in hopes of West Asia resolution. With earnings and macro conditions still fragile, analysts suggest the challenge for retail investors may now lie less in finding opportunities within SMIDs and more in avoiding the market's most overheated pockets.
